- Home
- SOBR vs PPBT Comparison
SOBR vs PPBT Comparison
Compare SOBR & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SOBR | PPBT |
|---|---|---|
| Founded | 2004 | 2010 |
| Country | United States | Israel |
| Employees | N/A | 10 |
| Industry | Newspapers/Magazines | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4M | 2.4M |
| IPO Year | 2008 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SOBR | PPBT |
|---|---|---|
| Price | $0.57 | $1.44 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $30.00 |
| AVG Volume (30 Days) | ★ 1.2M | 25.4K |
| Earning Date | 04-10-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 103.55 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $437,421.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 105.62 | N/A |
| 52 Week Low | $0.35 | $0.41 |
| 52 Week High | $3.95 | $5.18 |
Technical Indicators
Market Signals| Indicator | SOBR | PPBT |
|---|---|---|
| Relative Strength Index (RSI) | 45.09 | 48.09 |
| Support Level | $0.50 | $1.38 |
| Resistance Level | $0.62 | $1.85 |
| Average True Range (ATR) | 0.05 | 0.14 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 51.91 | 68.74 |
Price Performance
Historical ComparisonAbout SOBR SOBR Safe Inc.
Sobr Safe Inc is a hardware and software company. The Company integrates proprietary software, SOBRsafeTM, with its patented touch-based personal alcohol awareness tracking products, SOBRcheckTM and SOBRsure, enabling non-invasive personal alcohol awareness tracking, biometric identity verification, and qualified, real-time cloud-based, informational alerts and reporting. It operates as a single segment designed to enable customers to purchase products directly through channel partners, sales agents or through its enterprise and consumer digital channels. Currently its principal markets are located in North America.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.